Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.04.065Source: DataRank Database

Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial is a research paper published in Journal of the American College of Cardiology (2020). On theSindex it has a DataRank of 6.2. It has been cited 261 times, with 100 citing works in its 1-hop citation network.

N/A

6.2DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access261 citations · 100 citing works in its network

Free full text

Cite:

Linked data & code

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT00911508

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: bronzeTopics (15)Linked Datasets (22)DataCite Reuse (22)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 13%Citation Network 87%

Base Score Contribution

0.835

From this paper's citation signal

Citation Network Contribution

5.4

From 100 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 100 citers.

Management of atrial fibrillation in Russia: real clinical practice and current clinical guidelines
Journal of Arrhythmology20215 citations8 referencesContributes 0.224
Refractory atrial arrhythmias in Duchenne muscular dystrophy: a case series
HeartRhythm Case Reports20244 citations9 referencesContributes 0.179
Comparison of left atrial appendage closure and oral anti-coagulation after catheter ablation for atrial fibrillation: Concomitant and sequential cohorts of the OPTION randomized controlled trial
Heart Rhythm202515 citations20 referencesContributes 0.139
Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices
Circulation Arrhythmia and Electrophysiology202269 citations31 referencesContributes 0.137
Ablation of persistent atrial fibrillation: never say never again
European Heart Journal20245 citations15 referencesContributes 0.119

Authors (33)

Tristram D. Bahnson ORCID,Kristi H. Monahan ORCID,George Johnson,Hoss Rostami,A Silverstein ORCID

Live enrichment

PubMed:19910364

National Institutes of Health

Grant: 5U01HL089645-05

Cabana Image Analysis Lab

National Institutes of Health

Grant: 5U01HL089709-02

Catheter Ablation versus Antiarrythmic Drug Therapy for Atrial Fibrilllation Tria

National Institutes of Health

Grant: 5U01HL089907-04

CABANA EQOL Trial

National Institutes of Health

Grant: 5U01HL089786-05

CABANA-AF Trial

bronzeLicense: Elsevier Non-Commercial

publisherhttps://www.sciencedirect.com/science/article/pii/S0735109720351731/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0735109720351731?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0735109720351731?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8064404

https://doi.org/10.1016/j.jacc.2020.04.065

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

MaleIntention to Treat AnalysisTimeStrokeOutcome and Process Assessment, Health CareRecurrenceAtrial FibrillationCatheter AblationElectrocardiography, AmbulatoryHumansFemaleAnti-Arrhythmia AgentsAged

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056342.v1figshare

Additional file 1 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056342figshare

Additional file 2 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056345.v1figshare

Additional file 2 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056345figshare

Additional file 3 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056348.v1figshare

Additional file 3 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056348figshare

Additional file 1 of Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

10.6084/m9.figshare.26606953.v1figshare

Additional file 1 of Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

10.6084/m9.figshare.26606953figshare

Additional file 3 of Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

10.6084/m9.figshare.26606959.v1figshare

Additional file 2 of Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

10.6084/m9.figshare.26606956figshare

Additional file 4 of Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

10.6084/m9.figshare.26606962figshare

Additional file 4 of Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

10.6084/m9.figshare.26606962.v1figshare

Additional file 2 of Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

10.6084/m9.figshare.26606956.v1figshare

Additional file 3 of Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia

10.6084/m9.figshare.26606959figshare

Additional file 5 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056354figshare

Additional file 4 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056351.v1figshare

Additional file 6 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056357figshare

Additional file 7 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056360.v1figshare

Additional file 6 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056357.v1figshare

Additional file 7 of Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis

10.6084/m9.figshare.20056360figshare

Related Papers (1)

Epigenomic Assessment of Cardiovascular Disease Risk and Interactions With Traditional Risk Metrics

N/A

1.8DataRank · unranked

Journal of the American Heart Association(2020)

co-cited

10.1161/jaha.119.015299